GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BB Biotech BION.SW · CHF

N/A · SIX · 🇨🇭 Switzerland

Compare

53.50

+3.68%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CHF, from our data supplier.

FY2025

Revenue

CHF 76.8m

FY2016FY2025

Net income

CHF 578.1m

FY2016FY2025

Free cash flow

CHF 309.1m

FY2016FY2025

Shareholders' equity

CHF 2.78bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCHF 76.8mCHF 111.6mCHF 35,000−CHF 351.2m−CHF 396.2mCHF 699.2mCHF 685.2m−CHF 465.8mCHF 693.1m−CHF 796.4m
Gross profitCHF 76.8mCHF 111.6mCHF 35,000−CHF 351.2m−CHF 396.2mCHF 699.2mCHF 685.2m−CHF 465.8mCHF 693.1m−CHF 796.4m
Operating incomeCHF 586.8mCHF 84.4m−CHF 29.9m−CHF 356.0m−CHF 403.8mCHF 693.0mCHF 677.5m−CHF 470.2mCHF 688.1m−CHF 828.9m
Net incomeCHF 578.1mCHF 75.9m−CHF 206.6m−CHF 357.8m−CHF 404.8mCHF 691.2mCHF 677.4m−CHF 471.3mCHF 687.5m−CHF 802.1m
Diluted earnings per share10.481.39-3.77-6.52-7.3212.3412.21-8.4712.40-14.51

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCHF 2.79bnCHF 2.41bnCHF 2.64bnCHF 3.05bnCHF 3.64bnCHF 3.96bnCHF 3.55bnCHF 3.09bnCHF 3.64bnCHF 3.23bn
Cash and short-term investmentsCHF 99.4mCHF 2.41bnCHF 2.64bnCHF 3.05bnCHF 3.64bnCHF 3.96bnCHF 3.55bnCHF 22.1mCHF 10.7mCHF 10.2m
Total liabilitiesCHF 7.0mCHF 121.1mCHF 313.9mCHF 367.3mCHF 355.0mCHF 63.0mCHF 161.6mCHF 202.3mCHF 99.1mCHF 223.2m
Debt—CHF 117.5mCHF 304.9mCHF 363.0mCHF 355.0mCHF 63.0mCHF 150.0mCHF 185.0mCHF 95.0mCHF 205.0m
Shareholders' equityCHF 2.78bnCHF 2.29bnCHF 2.32bnCHF 2.69bnCHF 3.28bnCHF 3.89bnCHF 3.39bnCHF 2.88bnCHF 3.54bnCHF 3.00bn
Shares outstanding55m55m55m55m55m56m55m56m55m55m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCHF 309.1mCHF 304.6mCHF 218.3m−CHF 357.8m−CHF 404.8mCHF 262.4mCHF 215.0m−CHF 471.3mCHF 687.5m−CHF 802.1m
Free cash flowCHF 309.1mCHF 304.6mCHF 218.3m−CHF 357.8m−CHF 404.8mCHF 262.4mCHF 215.0m−CHF 471.3mCHF 687.5m−CHF 802.1m
Dividends paid−CHF 98.5m−CHF 109.7m−CHF 156.3m−CHF 212.2m−CHF 199.4m−CHF 188.4m−CHF 169.0m−CHF 182.8m−CHF 152.1m−CHF 160.5m

Financial ratios

Data as of 27 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin99.9%100.0%100.0%100.0%100.0%100.0%—
Operating margin764.0%72.0%-98865.7%101.4%102.2%98.9%—
Net margin752.7%68.0%-590305.7%101.9%102.2%98.8%—
Return on equity20.8%3.3%-8.9%-13.3%-12.3%17.8%—
Return on assets20.8%3.2%-7.8%-11.7%-11.1%17.4%—
Revenue growth-31.2%318848.6%-100.0%-11.4%-156.7%2.0%—
Earnings growth661.7%-136.7%-42.3%-11.6%-158.6%2.0%—
Current ratio—19.88x158.32x0.01x0.01x52.43x8.66x
Debt to equity—0.05x0.13x0.14x0.11x0.02x0.04x
Equity ratio99.7%95.0%88.1%88.0%90.1%98.1%—
Interest coverage1324.68x16.14x-5.96x-206.27x-410.49x782.84x—
Buybacks as a share of market value-0.6%0.1%0.0%0.8%1.2%-0.9%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue—-35.7%-19.3%
Operating income—-3.3%-1.1%
Net income—-3.5%-1.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin100.0%100.0%100.0%100.0%
Operating margin356.2%-175.3%409.6%141.3%
Net margin347.1%-55.1%268.0%122.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings4.325.6-11.3-8.5-10.56.05.4-6.95.2-3.8
Price to sales32.317.4—-8.6-10.85.95.4-7.05.2-3.8

Dividends and splits

Per share, in the currency the company pays

Paid for 13 years. Last went ex-dividend on 23 Mar 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year4.503.832.002.853.853.603.403.05
  • 5-for-1 split · 29 Mar 2016
  • 1-to-1 reverse split · 22 Apr 2008
  • 1-for-0.1 split · 18 May 2001
  • 1-for-0.2 split · 20 Nov 1997
  • 1-for-0.5 split · 4 Apr 1996

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.